Background: Urticaria pigmentosa (UP) is characterized by dense aggregates of mast cells in the dermis. There is consistent evidence from the literature that mast cells may play a pathogenetic role in the development of neurofibromas and other tumors. Objective: To study the concomitant appearance of UP with neurofibromas and neurofibroma-like neoplasms. Methods: We analyzed 31,752 records of patients examined at the Department of Dermatology in the year 2000, looking for UP and associated neurofibromas and neurofibroma-like neoplasms in persons younger than 18 years. Results: We identified a total of 27 patients suffering from UP, with 16 persons younger than 18 years. One 12-year-old Caucasian boy demonstrated multiple cutaneous mastocytomas consistent with the diagnosis of UP. On his trunk, four café-au-lait spots were found. A cutaneous neurofibroma was confirmed by skin biopsy. Magnetic resonance imaging detected multiple neoplasms located at the nerve roots of the spine, resembling plexiform neurofibromas. Conclusions: There may be a concomitant appearance of UP and neoplasms, with mast cells possibly playing a causative role. The existence of neoplasms, including neurofibromas and neurofibroma-like lesions should be considered when examining UP cases.

Keywords:
Mast cell, Urticaria pigmentosa, Neurofibroma, Oncogenesis
1.
Golkar L, Bernhard JD: Mastocytosis. Lancet 1997;349:1379–1385.
2.
Hurwitz S: Mastocytosis; in Hurwitz S (ed): Clinical Pediatric Dermatology, ed 2. Philadelphia, Saunders, 1993, pp 663–669.
3.
Lascano EF: Mast cells in human tumors. Cancer 1958;11:1110.
4.
Binnazi M, Landi G: Studio del mastociti nelle neurogliomatosi di Recklinghausen. J Ital Dermatol 1961;3:208–221.
5.
Riccardi VM: Neurofibromatosis: Clinical heterogeneity. Curr Probl Cancer 1982;7:1–34.
6.
Riccardi VM: Mast cell stabilization to decrease neurofibroma growth. Preliminary experience with ketotifen. Arch Dermatol 1988;123:1011–1016.
7.
Kirshenbaum AS, Kessler SW, Goff JP, Metcalfe DD: Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol 1991;146:1410–1415.
8.
Valent P, Horny H-P, Escribano L, et al: Diagnostic criteria and classification of matocytosis: A consensus proposal. Leuk Res 2001;25:603–625.
9.
Metcalfe DD: Conclusions. Clinical advances in mastocytosis: An interdisciplinary round table discussion. J Invest Dermatol 1991;96 (suppl):S64–S65.
10.
Longley BJ, Morganroth GS, Tyrrell L, et al: Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 1993;328:1302–1307.
11.
Longley BJ, Tyrrell L, Lu S-Z, et al: Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm. Nat Genet 1996;12:312–314.
12.
Horan RF: Mastocytosis; in Olbricht SM, Bigby ME, Arndt KA (eds): Manual of Clinical Problems in Dermatology. Boston, Little, Brown and Company, 1992, pp 243–247.
13.
Wolff K, Komar M, Petzelbauer P: Clinical and histopathological aspects of cutaneous mastocytosis. Leuk Res 2001;25:518–528.
14.
Kendall ME, Fields JP, King LE Jr: Cutaneous mastocytosis without clinically obvious skin lesions. J Am Acad Dermatol 1984;10:903–905.
15.
Nettleship E, Tay W: Rare forms of urticaria. BMJ 1869;2:323.
16.
Touraine A, Solente G, Renault P: Urticarie pigmentaire avec reaction splénique et myélinique. Bull Soc Franc Derm Syph 1933;40:1691.
17.
Klaus SN, Winkelman RK: Course of urticaria pigmentosa in children. Arch Dermatol 1962;86:116–119.
18.
Greggio H: Les cellules granuleuses (mastzellen) dans le tissues normaux et dans certaines maladies churgicales. Arch Méd Exp 1911;23:323.
19.
Mérot Y, Bauquis C, Saurat JH: Neurofibromatose de Von Recklinghausen et mastocytose systémique. Dermatologica 1984;168:25–30.
20.
Norrby K: Intradermal mast-cell secretion causing cutaneous mitogenesis. Virchows Arch B Cell Pathol Incl Mol Pathol 1983;42:263–269.
21.
Azizkhan RG, Azizkhan JC, Zetter BR, et al: Mast cell heparin stimulates migration of capillary endothelial cells in vitro. J Exp Med 1984;152:931–944.
22.
Reed JA, Albino AP, McNutt NS: Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest 1995;72:215–222.
23.
Riccadi VM: Cutaneous manifestations of neurofibromatosis: Cellular interaction, pigmentation and mast cells. Birth Defects 1981;17:129–145.
24.
Huston DP, Bressler RB, Kaliner M, et al: Prevention of mast cell degranulation in patients with physical urticaria. Ann Intern Med 1986;104:507–510.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.